Cannabinoids Sample Clauses

Cannabinoids. Opioid antagonists or agonists
Sample 1
AutoNDA by SimpleDocs
Cannabinoids. In recent years there has been exponential increase in the interest among physicians and the general public about the potential of cannabinoids, cannabidiol in particular, for the treatment of epilepsy (Xxxxxxx, 2017). Class I evidence is now available indicating that cannabidiol added on to other antiepileptic drugs (AEDs) improves seizure control in patients with Dravet syndrome (Devinsky et al. 2017) and Lennox- Gastaut-syndrome (Devinsky et al, 2018; Xxxxxx et al, 2018), but high-quality evidence for its potential usefulness in the management of other epilepsy syndromes is still lacking. The results of the present survey show that exploration of the potential value of cannabidiol in a wide range of other seizure types and epileptic syndromes remains a high priority in the epilepsy community. It has also been suggested that the combination of cannabidiol and tetrahydrocannabidiol could bring antiseizure benefits superior to those associated with cannabidiol alone (XxXxx et al, 2018), and assessment of the potential added value of this combination was also recommended by one survey participant. The WP V TF concurred that high quality trials on the value of cannabinoids in epilepsy are worth pursuing. There was consensus that any such trial should make use of pharmaceutical-grade formulations, because there is evidence that some commercially available artisanal products may not contain the stated amount of cannabinoids, and may even contain harmful contaminants (Xxxxxxx, 2017).
Sample 1
Cannabinoids. Those chemical substances that link with the cannabinoid receptors of the body and the brain, and they can be classified in Phytocannabinoids, Endocannabinoids and synthetic Cannabinoids, among the most common Phytocannabinoids we have: CBD (Cannabidiol), CBN (Cannabinol), CBG (Cannabigerol) and THC (Tetrahydrocannabinol).
Sample 1
Cannabinoids. This group represents the most studied compounds from cannabis. The term cannabinoid is given to the terpenophenolic compounds with 22 carbons (or 21 carbons for neutral form) of which 70 cannabinoids have been found so far and which can be divided into 10 main structural types (Figure 1). All other compounds that do not fit into the main types are grouped as miscellaneous (Figure 2). The neutral compounds are formed by decarboxylation of the unstable corresponding acids. Although decarboxylation occurs in the living plant, it increases during storage after harvesting, especially at elevated temperatures (Mechoulam and Xxx-Xxxxxx, 1999). Both forms are also further degraded into secondary products by the effects of temperature, light (Xxxxx and Xxxxxx, 1978) and auto-oxidation (Xxxxxx et al., 1972). OH R2 OH R2 OH R R" OH R2 R5O R3 O R3 OR R3 O R3 5 Cannabigerol (CBG) type R2: H or COOH R3: C3 or C5 side chain R5: H or CH3 Cannabichromene (CBC) type R2: H or COOH R3: C3 or C5 = , S-configuration Cannabidiol (CBD) type R2: H or COOH R3: C1, C3, C4 or C5 side chain R5: H or CH3 Cannabitriol (CBT) type R3: C3 or C5 side chain R: H or OH R’: H or CBDA-C5 ester R”: H, OH or OEt = , R-configuration HO H H H OH H R2 O R2 OH O R3 H Cannabicyclol (CBL) type R2: H or COOH R3: C3 or C5 side chain OH R3 R4 OH R3 Cannabielsoin (CBE) type R2: H or COOH R3: C3 or C5 R4: COOH or H Cannabinodiol (CBND) type R3: C3 or C5 side chain OR H OH 1 R2 R2 H OH O R3 R2 O H R3 R4 Cannabinol (CBN) type R1: H or CH3 R2: H or COOH R3: C1, C2, C3, C4 or C5 side chain O Δ8-Tetrahydrocannabinol (Δ8-THC) type R2: H or COOH Δ9-Tetrahydrocannabinol (Δ9-THC) type R2 or R4: H or COOH R3: C1, C3, C4 or C5 side chain R4: COOH or H Figure 1. Cannabinoid structural types. In cannabis, the most prevalent compounds are Δ9-THC acid, CBD acid and CBN acid, followed by CBG acid, CBC acid and CBND acid, while the others are minor compounds. Based on the absolute concentration of Δ9-THC (Δ9-THC+ Δ9-THC acid) and CBD (CBD + CBD acid) obtained via HPLC or GC analyses, the plants are classified as follows: Drug type (chemotype I), the concentration of Δ9-THC is more than 2% and CBD concentration is less 0.5%; Fiber type (chemotype III), the Δ9-THC concentration is less than 0.3% and the concentration of CBD is more than 0.5%; Intermediate type (chemotype II), the concentrations of both are similar, usually more than 0.5% for each; and Propyl isomer/C3 type (chemotype IV), which can be differentiated by the d...
Sample 1

Related to Cannabinoids

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Animals The Hirer shall ensure that no animals (including birds) except guide dogs are brought into the premises, other than for a special event agreed to by the Village Hall. No animals whatsoever are to enter the kitchen at any time.

  • Drugs Possession or use of drugs by the Student, any person present in the residence with the Student, or any person present in the Student’s residence with the permission of the Student during the Student’s absence, are strictly prohibited in any UCF DHRL facility. Prohibited drugs include, but are not limited to: A. any substance, the possession or use of which, regardless of amount, could be found to violate Federal or Florida drug abuse prevention and control laws; B. any prescription medication for which the possessor/user does not have a presently valid medical prescription.

  • Prosthodontics We Cover prosthodontic services as follows:

  • Nepotism No employee shall be directly supervised by a member of his/her immediate family. “

  • Weapons We have a zero tolerance of the possession of weapons (sword, knives etc) or firearms (guns etc) in the Room, Building or Common Property. If You are found in possession of weapons, firearms or implements associated with their use in the Room, Building or Common Property We will immediately terminate this agreement and inform the relevant UNSW and legal authorities.

  • Medication 1. Xxxxxxx’s physician shall prescribe and monitor adequate dosage levels for each Client. 2. Xxxxxxx’s physician shall not impose and/or limit dosage capitations for any prescribed medication for the treatment of opioid use disorder.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!